Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07271524Not ApplicableNot Yet Recruiting

Non-invasive Deep Brain Stimulation to Improve Spatial Navigation Abilities in Individuals Following Traumatic Brain Injury

Role: collaborator

NCT07092839Not ApplicableCompleted

Non-invasive Deep Brain Stimulation to Enhance Motor Skill Acquisition in Individuals With Mild Cognitive Impairment

Role: collaborator

NCT04658238Recruiting

Ocular Microbiome and Immune System in Dry Eyes

Role: collaborator

NCT06822283Not ApplicableCompleted

Plasticity of Deep Brain Structures in Mild Cognitive Impairment and Healthy Aging

Role: collaborator

All 4 trials loaded